Logo image of PRGO

PERRIGO CO PLC (PRGO) Stock Fundamental Analysis

NYSE:PRGO - New York Stock Exchange, Inc. - IE00BGH1M568 - Common Stock - Currency: USD

26.77  -0.36 (-1.33%)

After market: 26.77 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRGO. PRGO was compared to 195 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PRGO while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on PRGO. PRGO also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PRGO had positive earnings in the past year.
In the past year PRGO had a positive cash flow from operations.
PRGO had negative earnings in each of the past 5 years.
PRGO had a positive operating cash flow in each of the past 5 years.
PRGO Yearly Net Income VS EBIT VS OCF VS FCFPRGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

PRGO has a Return On Assets of -1.85%. This is in the better half of the industry: PRGO outperforms 80.00% of its industry peers.
With an excellent Return On Equity value of -4.13%, PRGO belongs to the best of the industry, outperforming 80.51% of the companies in the same industry.
PRGO's Return On Invested Capital of 3.66% is amongst the best of the industry. PRGO outperforms 80.51% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PRGO is significantly below the industry average of 14.70%.
The last Return On Invested Capital (3.66%) for PRGO is above the 3 year average (2.21%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.85%
ROE -4.13%
ROIC 3.66%
ROA(3y)-1.06%
ROA(5y)-1.05%
ROE(3y)-2.38%
ROE(5y)-2.27%
ROIC(3y)2.21%
ROIC(5y)2.9%
PRGO Yearly ROA, ROE, ROICPRGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With an excellent Operating Margin value of 9.28%, PRGO belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
In the last couple of years the Operating Margin of PRGO has grown nicely.
PRGO has a Gross Margin (36.38%) which is in line with its industry peers.
In the last couple of years the Gross Margin of PRGO has remained more or less at the same level.
Industry RankSector Rank
OM 9.28%
PM (TTM) N/A
GM 36.38%
OM growth 3Y-22.79%
OM growth 5Y3.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y-0.98%
PRGO Yearly Profit, Operating, Gross MarginsPRGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRGO is destroying value.
The number of shares outstanding for PRGO has been increased compared to 1 year ago.
The number of shares outstanding for PRGO has been increased compared to 5 years ago.
The debt/assets ratio for PRGO has been reduced compared to a year ago.
PRGO Yearly Shares OutstandingPRGO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
PRGO Yearly Total Debt VS Total AssetsPRGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that PRGO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.84, PRGO perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of PRGO is 20.03, which is on the high side as it means it would take PRGO, 20.03 years of fcf income to pay off all of its debts.
PRGO has a better Debt to FCF ratio (20.03) than 77.44% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that PRGO is somewhat dependend on debt financing.
PRGO has a Debt to Equity ratio of 0.82. This is in the lower half of the industry: PRGO underperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 20.03
Altman-Z 0.84
ROIC/WACC0.49
WACC7.47%
PRGO Yearly LT Debt VS Equity VS FCFPRGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 2.36 indicates that PRGO has no problem at all paying its short term obligations.
PRGO's Current ratio of 2.36 is in line compared to the rest of the industry. PRGO outperforms 43.08% of its industry peers.
A Quick Ratio of 1.28 indicates that PRGO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.28, PRGO is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 1.28
PRGO Yearly Current Assets VS Current LiabilitesPRGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.60% over the past year.
PRGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.68% yearly.
The Revenue has decreased by -4.84% in the past year.
Measured over the past years, PRGO shows a small growth in Revenue. The Revenue has been growing by 2.48% on average per year.
EPS 1Y (TTM)18.6%
EPS 3Y7.69%
EPS 5Y-8.68%
EPS Q2Q%106.9%
Revenue 1Y (TTM)-4.84%
Revenue growth 3Y1.86%
Revenue growth 5Y2.48%
Sales Q2Q%-3.53%

3.2 Future

PRGO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.76% yearly.
PRGO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.27% yearly.
EPS Next Y20.89%
EPS Next 2Y13.97%
EPS Next 3Y11.77%
EPS Next 5Y8.76%
Revenue Next Year-0.15%
Revenue Next 2Y1.05%
Revenue Next 3Y1.52%
Revenue Next 5Y1.27%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PRGO Yearly Revenue VS EstimatesPRGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
PRGO Yearly EPS VS EstimatesPRGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

PRGO is valuated reasonably with a Price/Earnings ratio of 9.33.
91.28% of the companies in the same industry are more expensive than PRGO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.25. PRGO is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.05, the valuation of PRGO can be described as reasonable.
Based on the Price/Forward Earnings ratio, PRGO is valued cheaper than 87.69% of the companies in the same industry.
PRGO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 9.33
Fwd PE 8.05
PRGO Price Earnings VS Forward Price EarningsPRGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRGO is valued cheaper than 86.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRGO indicates a rather cheap valuation: PRGO is cheaper than 82.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.17
EV/EBITDA 9.46
PRGO Per share dataPRGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

PRGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRGO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y13.97%
EPS Next 3Y11.77%

7

5. Dividend

5.1 Amount

PRGO has a Yearly Dividend Yield of 4.28%, which is a nice return.
Compared to an average industry Dividend Yield of 4.15, PRGO pays a better dividend. On top of this PRGO pays more dividend than 96.41% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, PRGO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

On average, the dividend of PRGO grows each year by 6.29%, which is quite nice.
PRGO has been paying a dividend for at least 10 years, so it has a reliable track record.
PRGO has decreased its dividend recently.
Dividend Growth(5Y)6.29%
Div Incr Years1
Div Non Decr Years1
PRGO Yearly Dividends per sharePRGO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of PRGO are negative and hence is the payout ratio. PRGO will probably not be able to sustain this dividend level.
The dividend of PRGO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-86.25%
EPS Next 2Y13.97%
EPS Next 3Y11.77%
PRGO Yearly Income VS Free CF VS DividendPRGO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

PERRIGO CO PLC

NYSE:PRGO (5/30/2025, 8:27:24 PM)

After market: 26.77 0 (0%)

26.77

-0.36 (-1.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners102.47%
Inst Owner Change0.9%
Ins Owners0.35%
Ins Owner Change9.6%
Market Cap3.65B
Analysts76.36
Price Target35.19 (31.45%)
Short Float %3.84%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend1.12
Dividend Growth(5Y)6.29%
DP-86.25%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-30 2025-05-30 (0.29)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3%
Min EPS beat(2)-1.43%
Max EPS beat(2)7.44%
EPS beat(4)2
Avg EPS beat(4)4.42%
Min EPS beat(4)-2.11%
Max EPS beat(4)13.78%
EPS beat(8)6
Avg EPS beat(8)8.15%
EPS beat(12)8
Avg EPS beat(12)4.45%
EPS beat(16)9
Avg EPS beat(16)-1.08%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-6.62%
Max Revenue beat(2)-5.79%
Revenue beat(4)0
Avg Revenue beat(4)-6.07%
Min Revenue beat(4)-7.19%
Max Revenue beat(4)-4.69%
Revenue beat(8)0
Avg Revenue beat(8)-5%
Revenue beat(12)1
Avg Revenue beat(12)-4.09%
Revenue beat(16)1
Avg Revenue beat(16)-3.7%
PT rev (1m)0%
PT rev (3m)1.47%
EPS NQ rev (1m)-4.3%
EPS NQ rev (3m)-12.5%
EPS NY rev (1m)1.58%
EPS NY rev (3m)-0.51%
Revenue NQ rev (1m)0.64%
Revenue NQ rev (3m)-3.75%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE 9.33
Fwd PE 8.05
P/S 0.84
P/FCF 20.17
P/OCF 12.18
P/B 0.84
P/tB N/A
EV/EBITDA 9.46
EPS(TTM)2.87
EY10.72%
EPS(NY)3.33
Fwd EY12.42%
FCF(TTM)1.33
FCFY4.96%
OCF(TTM)2.2
OCFY8.21%
SpS31.77
BVpS31.98
TBVpS-10.8
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -4.13%
ROCE 4.63%
ROIC 3.66%
ROICexc 3.84%
ROICexgc 13.02%
OM 9.28%
PM (TTM) N/A
GM 36.38%
FCFM 4.18%
ROA(3y)-1.06%
ROA(5y)-1.05%
ROE(3y)-2.38%
ROE(5y)-2.27%
ROIC(3y)2.21%
ROIC(5y)2.9%
ROICexc(3y)2.37%
ROICexc(5y)3.33%
ROICexgc(3y)9.14%
ROICexgc(5y)12.63%
ROCE(3y)2.79%
ROCE(5y)3.67%
ROICexcg growth 3Y-27.17%
ROICexcg growth 5Y8.08%
ROICexc growth 3Y-25.01%
ROICexc growth 5Y10.11%
OM growth 3Y-22.79%
OM growth 5Y3.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y-0.98%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 20.03
Debt/EBITDA 4.94
Cap/Depr 36.59%
Cap/Sales 2.74%
Interest Coverage 250
Cash Conversion 41.27%
Profit Quality N/A
Current Ratio 2.36
Quick Ratio 1.28
Altman-Z 0.84
F-Score5
WACC7.47%
ROIC/WACC0.49
Cap/Depr(3y)31.02%
Cap/Depr(5y)43.56%
Cap/Sales(3y)2.35%
Cap/Sales(5y)3.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.6%
EPS 3Y7.69%
EPS 5Y-8.68%
EPS Q2Q%106.9%
EPS Next Y20.89%
EPS Next 2Y13.97%
EPS Next 3Y11.77%
EPS Next 5Y8.76%
Revenue 1Y (TTM)-4.84%
Revenue growth 3Y1.86%
Revenue growth 5Y2.48%
Sales Q2Q%-3.53%
Revenue Next Year-0.15%
Revenue Next 2Y1.05%
Revenue Next 3Y1.52%
Revenue Next 5Y1.27%
EBIT growth 1Y81.86%
EBIT growth 3Y-21.35%
EBIT growth 5Y6.28%
EBIT Next Year39.05%
EBIT Next 3Y16.52%
EBIT Next 5Y10.62%
FCF growth 1Y22.12%
FCF growth 3YN/A
FCF growth 5Y19.35%
OCF growth 1Y21.08%
OCF growth 3Y32.42%
OCF growth 5Y-1.32%